Thank you for participating in ENDO 2021, which featured a combination of live and on-demand programming. Note that this evaluation is for ENDO 2021 as a whole, not individual sessions.  Participants are given the option to choose one evaluation/credit path and, after completing the evaluation, w

Thank you for participating in ENDO 2021, which featured a combination of live and on-demand programming. Note that this evaluation is for ENDO 2021 as a whole, not individual sessions.

Thank you for participating in ENDO 2021, which featured a combination of live and on-demand programming. Note that this evaluation is for ENDO 2021 as a whole, not individual sessions.

Thank you for participating in ENDO 2021, which featured a combination of live and on-demand programming. Note that this evaluation is for ENDO 2021 as a whole, not individual sessions.  Participants are given the option to choose one evaluation/credit path and, after completing the evaluation, w

Tuesday, March 23, 2021
Program:5:30 PM – 7:00 PM EDT  

This interactive symposium will review gaps in current hypoparathyroidism management, and explore new/emerging options and how they can help overcome current barriers to successful management.

Monday, March 22, 2021
Program: 8:30 AM – 10:00 AM EDT  

Join us for a discussion of:
• The Diagnosis & Medical Management of Hypophosphatemia
• X-linked Hypophosphatemia: From Childhood to Adulthood

Saturday, March 20, 2021
Program: 5:30 PM – 7:00 PM EDT  

Expert faculty will discuss:
• Current guidelines and diagnostic testing performance in the diagnosis of Cushing’s disease

Join us for a discussion of the diagnosis and clinical management of late endocrine effects in pediatric and adult cancer survivors.

Join us virtually for two days of live programming as we explore recent developments in technology and endocrine research. Hear how your peers are applying new technology and learn new methods for approaching research in your lab.

Tune into this webinar to learn more about the principles, risks and benefits of gender affirming hormone replacement therapy (HRT) and understand the informed consent and risk reduction models.

Pages

Subscribe to RSS - Live Meeting